Teija Parkkari

Title: Teija Parkkari: Innovator in Cannabinoid Receptor Modulation

Introduction

Teija Parkkari is a notable inventor based in Kuopio, Finland. She has made significant contributions to the field of cannabinoid research, particularly through her innovative patent related to the modulation of cannabinoid receptors. Her work is essential in understanding and treating various disorders linked to these receptors.

Latest Patents

Teija Parkkari holds a patent titled "Inhibitors of fatty acid amide hydrolase and monoacylglycerol lipase for modulation of cannabinoid receptors." This patent discloses compounds and compositions that inhibit the action of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MGL). The methods outlined in her patent focus on modulating cannabinoid receptors and treating disorders associated with their modulation. She has 1 patent to her name.

Career Highlights

Teija Parkkari is affiliated with Northeastern University, where she continues her research and development in cannabinoid receptor modulation. Her academic and professional journey reflects her dedication to advancing scientific knowledge in this critical area.

Collaborations

Teija has collaborated with esteemed colleagues, including Alexandros Makriyannis and Lakshmipathi Pandarinathan. These partnerships enhance her research and contribute to the broader scientific community.

Conclusion

Teija Parkkari's innovative work in cannabinoid receptor modulation showcases her expertise and commitment to advancing medical science. Her contributions are vital for future developments in treating disorders related to cannabinoid receptors.